Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures

Nature Medicine

Volumn 20, Issue 11, 2014, Pages 1279-1288

  Movérare Skrtic, Sofia ^a   Henning, Petra ^a   Liu, Xianwen ^b,c,q   Nagano, Kenichi ^b   Saito, Hiroaki ^b,r   Börjesson, Anna E ^a   Sjögren, Klara ^a   Windahl, Sara H ^a   Farman, Helen ^a   Kindlund, Bert ^a   Engdahl, Cecilia ^a   Koskela, Antti ^d   Zhang, Fu Ping ^e   Eriksson, Emma E ^f   Zaman, Farasat ^f,g   Hammarstedt, Ann ^h   Isaksson, Hanna ^i,j   Bally, Marta ^k   Kassem, Ali ^l   Lindholm, Catharina ^a   Sandberg, Olof ^m   Aspenberg, Per ^m   Sävendahl, Lars ^f   Feng, Jian Q ⁿ   Tuckermann, Jan ^o   Tuukkanen, Juha ^d   Poutanen, Matti ^a,e   Baron, Roland ^b,p   Lerner, Ulf H ^a,l   Gori, Francesca ^b,p   Ohlsson, Claes ^a   more..

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY OF OULU   (Finland)

^e Institute of Biomedicine   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ LUND UNIVERSITY   (Sweden)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^l UMEÅ UNIVERSITY   (Sweden)

^m LINKÖPING UNIVERSITY   (Sweden)

ⁿ BAYLOR COLLEGE OF DENTISTRY   (United States)

^o UNIVERSITY OF ULM   (Germany)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q SOUTHERN MEDICAL UNIVERSITY   (China)

^r UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; JANUS KINASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN C JUN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT16 PROTEIN; WNT16 PROTEIN, HUMAN; WNT16 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MASS; BONE MATURATION; CONTROLLED STUDY; CORTICAL BONE; ENZYME PHOSPHORYLATION; FEMALE; FRAGILITY FRACTURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; PHENOTYPE; POROSITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TIBIA; TRABECULAR BONE; AGING; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; DEFICIENCY; DISEASE PREDISPOSITION; DRUG EFFECTS; FRACTURES, BONE; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ORGAN SIZE; OSTEOCLAST; PATHOLOGY; SIGNAL TRANSDUCTION; SKULL;

MUS;

AGING; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; FRACTURES, BONE; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MICE, INBRED C57BL; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS; OSTEOPROTEGERIN; RANK LIGAND; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKULL; WNT PROTEINS;

EID: 84922395264     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3654     Document Type: Article

References (66)

1. Baron, R. & Hesse, E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J. Clin. Endocrinol. Metab. 97, 311-325 (2012).
2. Zebaze, R.M. et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375, 1729-1736 (2010).
3. Holzer, G., von Skrbensky, G., Holzer, L.A. & Pichl, W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J. Bone Miner. Res. 24, 468-474 (2009).
4. Zheng, H.F. et al. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet. 8, e1002745 (2012).
5. Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192 (2013).
6. Cadigan, K.M. & Peifer, M. Wnt signaling from development to disease: insights from model systems. Cold Spring Harb. Perspect. Biol. 1, a002881 (2009).
7. Jenny, A. Planar cell polarity signaling in the Drosophila eye. Curr. Top. Dev. Biol. 93, 189-227 (2010).
8. Kohn, A.D. & Moon, R.T. Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium 38, 439-446 (2005).
9. Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523 (2001).
10. Little, R.D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11-19 (2002).
11. Boyden, L.M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521 (2002).
12. Brunkow, M.E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577-589 (2001).
13. Balemans, W. et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91-97 (2002).
14. Kramer, I. et al. Osteocyte Wnt/β-catenin signaling is required for normal bone homeostasis. Mol. Cell. Biol. 30, 3071-3085 (2010).
15. Glass, D.A. II et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764 (2005).
16. Miclea, R.L. et al. Adenomatous polyposis coli-mediated control of β-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev. Biol. 9, 26 (2009).
17. Bennett, C.N. et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J. Bone Miner. Res. 22, 1924-1932 (2007).
18. Kato, M. et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303-314 (2002).
19. Bonewald, L.F. & Johnson, M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 42, 606-615 (2008).
20. Holmen, S.L. et al. Essential role of β-catenin in postnatal bone acquisition. J. Biol. Chem. 280, 21162-21168 (2005).
21. Day, T.F., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750 (2005).
22. Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W. & Hartmann, C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727-738 (2005).
23. Wei, W. et al. Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin. Mol. Cell. Biol. 31, 4706-4719 (2011).
24. Maeda, K. et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405-412 (2012).
25. Estrada, K. et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet. 44, 491-501 (2012).
26. Medina-Gomez, C. et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 8, e1002718 (2012).
27. Koller, D.L. et al. Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J. Bone Miner. Res. 28, 547-558 (2013).
28. García-Ibarbia, C. et al. Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures. Osteoporos. Int. 24, 2449-2454 (2013).
29. Hendrickx, G. et al. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters. Bone 59, 57-65 (2014).
30. Brommage, R., Liu, J., Revelli, J., Kirkpatrick, L. & Powwell, D. Gene knockouts of Wnt10b and Wnt16 in mice result in low bone mass. Bone 40, S187 (2007).
31. Huang, S.M. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620 (2009).
32. Teh, M.T. et al. Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J. Cell Sci. 120, 330-339 (2007).
33. Liu, Y., Ross, J.F., Bodine, P.V. & Billiard, J. Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3β phosphorylation and promotes osteoblast differentiation and bone formation. Mol. Endocrinol. 21, 3050-3061 (2007).
34. Liu, Y., Rubin, B., Bodine, P.V. & Billiard, J. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J. Cell. Biochem. 105, 497-502 (2008).
35. Rauch, A. et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11, 517-531 (2010).
36. Lu, Y. et al. DMP1-targeted Cre expression in odontoblasts and osteocytes. J. Dent. Res. 86, 320-325 (2007).
37. Kim, J. et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. J. Bone Miner. Res. 28, 2381-2391 (2013).
38. Wermelin, K., Suska, F., Tengvall, P., Thomsen, P. & Aspenberg, P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone 42, 365-371 (2008).
39. Zhong, Z. et al. Wntless functions in mature osteoblasts to regulate bone mass. Proc. Natl. Acad. Sci. USA 109, E2197-E2204 (2012).
40. Bennett, C.N. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. USA 102, 3324-3329 (2005).
41. Stevens, J.R. et al. Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J. Bone Miner. Res. 25, 2138-2147 (2010).
42. Green, J.L. et al. Use of a molecular genetic platform technology to produce human Wnt proteins reveals distinct local and distal signaling abilities. PLoS ONE 8, e58395 (2013).
43. Guo, X. et al. Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 18, 2404-2417 (2004).
44. Lu, D. et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 101, 3118-3123 (2004).
45. Sugimura, R. et al. Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche. Cell 150, 351-365 (2012).
46. Jiang, Z., Von den Hoff, J.W., Torensma, R., Meng, L. & Bian, Z. Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/β-catenin pathway. J. Cell. Physiol. 229, 384-392 (2014).
47. Santiago, F., Oguma, J., Brown, A.M. & Laurence, J. Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir. Biochem. Biophys. Res. Commun. 417, 223-230 (2012).
48. van Amerongen, R. & Nusse, R. Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214 (2009).
49. Valenzuela, D.M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652-659 (2003).
50. Windahl, S.H. et al. Estrogen receptor-a in osteocytes is important for trabecular bone formation in male mice. Proc. Natl. Acad. Sci. USA 110, 2294-2299 (2013).
51. Maes, C. et al. Increased skeletal VEGF enhances β-catenin activity and results in excessively ossified bones. EMBO J. 29, 424-441 (2010).
52. Windahl, S.H., Vidal, O., Andersson, G., Gustafsson, J.A. & Ohlsson, C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ-/- mice. J. Clin. Invest. 104, 895-901 (1999).
53. Vidal, O. et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl. Acad. Sci. USA 97, 5474-5479 (2000).
54. Movérare, S. et al. Differential effects on bone of estrogen receptor a and androgen receptor activation in orchidectomized adult male mice. Proc. Natl. Acad. Sci. USA 100, 13573-13578 (2003).
55. Waarsing, J.H., Day, J.S. & Weinans, H. An improved segmentation method for in vivo microCT imaging. J. Bone Miner. Res. 19, 1640-1650 (2004).
56. Hildebrand, T. & Ruegsegger, P. Quantification of bone microarchitecture with the structure model index. Comput. Methods Biomech. Biomed. Engin. 1, 15-23 (1997).
57. Parfitt, A.M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610 (1987).
58. Baron, R., Vignery, A., Neff, L., Silverglate,, A. & Santa Maria, A. Processing of undecalcified bone specimens for bone histomorphometry. in Bone Histomorphometry: Techniques and Interpretation (ed. Recker, R.) 13-35 (CRC Press Inc., Boca Raton, 1983).
59. Eriksen, E., Axelrod, D. & Melsen, F. Bone Histomorphometry (Raven, New York, 1994).
60. Hayman, A.R., Macary, P., Lehner, P.J. & Cox, T.M. Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J. Histochem. Cytochem. 49, 675-684 (2001).
61. Granholm, S., Henning, P., Lindholm, C. & Lerner, U.H. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. Bone 52, 83-92 (2013).
62. Stanford, C.M., Jacobson, P.A., Eanes, E.D., Lembke, L.A. & Midura, R.J. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270, 9420-9428 (1995).
63. Granholm, S., Lundberg, P. & Lerner, U.H. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-κB and c-Fms. J. Endocrinol. 195, 415-427 (2007).
64. Takeshita, S., Kaji, K. & Kudo, A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477-1488 (2000).
65. Morrell, N.T. et al. Liposomal packaging generates Wnt protein with in vivo biological activity. PLoS ONE 3, e2930 (2008).
66. Agholme, F., Li, X., Isaksson, H., Ke, H.Z. & Aspenberg, P. Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J. Bone Miner. Res. 25, 2412-2418 (2010).